Subuxone Film 8mg/2mg

Buprenorphine (as HCl), naloxone (as HCl dihydrate); 2mg/0.5mg, 4mg/1mg, 8mg/2mg, 12mg/3mg; sublingual films; lime-flavor.

Category:

Subuxone Film 8mg/2mg

Suboxone is a sublingual medicine that is combined with Buprenorphine and Naloxone. This medicine is famously known as narcotic medicine. It blocks the different drugs that affect the body and provide a fresh appearance. It also works as a pain reliever, in many cases. Many people prefer to order Suboxone COD to get the medicine at their doorstep. One should consume this drug with a doctor’s suggestion. The doctor will provide proper guidance on the dosage of this drug. Methodically, it can be said that people should read the user guideline on the medicine package before using it. 

How to Use Suboxone?

Treatment of opioid dependence, as part of a complete treatment plan to include counseling and psychosocial support.

Do not cut, chew or swallow. Avoid food or drinks until film dissolves. Give by sublingual (SL: under the tongue) or buccal (inside of cheek) administration. Place additional films sublingually or buccally on opposite side from the first film if needed; should minimize overlapping. Start when clear signs of withdrawal occur; individualize based on type and degree of opioid dependence. Supervised induction (use SL route): Day 1: initially 2mg/0.5mg or 4mg/1mg; may increase in increments of buprenorphine 2mg or 4mg at 2-hr intervals, up to 8mg/2mg based on response; Day 2: a single dose up to 16mg/4mg. Dependent on heroin or short-acting opioids: initiate induction with either Suboxone film or buprenorphine monotherapy (SL tabs) at least 6hrs after last opioid dose.

Some Important Information About Suboxone

Dependent on methadone or long-acting opioids: initiate buprenorphine monotherapy (SL tabs) for induction, then transition to once daily Suboxone. Maintenance phase: (target dose): 16mg/4mg once daily; adjust in 2mg/0.5mg or 4mg/1mg increments/decrements; (usual range): 4mg/1mg–24mg/6mg once daily. Switching between buprenorphine or buprenorphine/naloxone tabs and Suboxone films: start on same dosage as previously; may need dose adjustments between products; monitor for over- or under-dosing. Switching between various Suboxone film strengths: systemic exposures may be different; monitor for over- or under-dosing. Hepatic impairment (severe): not recommended; (moderate): avoid use for induction. Concomitant use or discontinuation of CYP3A4 inhibitors or inducers: monitor closely and consider dose adjustments (see full labeling).

Reviews

There are no reviews yet.

Be the first to review “Subuxone Film 8mg/2mg”

Your email address will not be published.